Anders Fink-Jensen

Medicine & Life Sciences

1. Antipsychotic Agents 100%
2. Schizophrenia 92%
3. Cocaine 68%
4. Aripiprazole 55%
5. Muscarinic Receptors 55%
6. Glucagon-Like Peptide-1 Receptor 54%
7. Psychotic Disorders 43%
8. Dopamine 41%
9. Alcohols 40%
10. Self Administration 38%
11. Quetiapine Fumarate 38%
12. Muscarinic M4 Receptors 36%
13. Clozapine 30%
14. Exenatide 29%
15. Olanzapine 28%
16. xanomeline 27%
17. Knockout Mice 24%
18. Amphetamine 24%
19. Child 23%
20. Psychiatry 23%
21. Systematic Reviews 21%
22. Haplorhini 20%
23. Alcohol Drinking 20%
24. Prediabetic State 20%
25. Liraglutide 20%
26. Therapeutics 20%
27. Social Isolation 19%
28. Cholinergic Receptors 19%
29. neuropeptide Y5 receptor 18%
30. Nucleus Accumbens 18%
31. Neuropeptide Y Receptors 17%
32. Pharmaceutical Preparations 17%
33. Hip 17%
34. Sapajus apella 17%
35. Muscarinic M1 Receptors 16%
36. Placebos 16%
37. Substance-Related Disorders 15%
38. Glucagon-Like Peptide 1 15%
39. Overweight 15%